Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | -16.67% | 0.00% | -16.67% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18/19/18 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18/19/18 |
William Jackson
BRD | Director/Board Member | - | 01/14/01 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 18/19/18 |
Director/Board Member | 50 | 18/19/18 | |
Joshua Herman
BRD | Director/Board Member | - | 18/19/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 418,564,269 | 412,444,735 ( 98.54 %) | 0 | 98.54 % |
Company contact information
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.comSector
1st Jan change | Capi. | |
---|---|---|
-16.67% | 9.18M | |
+8.69% | 105B | |
-0.79% | 104B | |
+5.79% | 22.94B | |
-12.24% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.92% | 16.96B | |
+8.13% | 14.16B | |
+39.85% | 12.63B |
- Stock Market
- Equities
- RVV Stock
- Company Revive Therapeutics Ltd.